{{Drugbox
| verifiedrevid = 464380766
| IUPAC_name = (2''S'')-2-[(2''R'')-2-benzyl-3-(2-methylpropane-2-sulfonyl)propanamido]-''N''-[(2''R'',3''S'',4''R'')-1-cyclohexyl-4-cyclopropyl-3,4-dihydroxybutan-2-yl]-3-(1''H''-imidazol-4-yl)propanamide
| image = Remikiren.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status = Investigational

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 126222-34-2
| ATC_prefix = C09
| ATC_suffix = XA01
| PubChem = 6324659
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00212
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4884377
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = LC7FBL96A4
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D09038
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 31601

<!--Chemical data-->
| C=33 | H=50 | N=4 | O=6 | S=1 
| molecular_weight = 630.839 g/mol
| smiles = O=S(=O)(C(C)(C)C)C[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C2CC2)Cc3cncn3)Cc4ccccc4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25-,27+,28+,29+,30-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UXIGZRQVLGFTOU-VQXQMPIVSA-N
}}

'''Remikiren''' is a [[renin inhibitor]] under development for the treatment of [[hypertension]] (high blood pressure). It was first developed by [[Hoffmann–La Roche]] in 1996.<ref>{{cite journal |vauthors=Richter WF, Whitby BR, Chou RC |title=Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals |journal=Xenobiotica |volume=26 |issue=3 |pages=243–54 |year=1996 |pmid=8730917 |doi=10.3109/00498259609046705}}</ref>

==References==
<references/>

{{Agents acting on the renin-angiotensin system}}
{{Angiotensin receptor modulators}}

[[Category:Renin inhibitors]]
[[Category:Cyclopropanes]]


{{cardiovascular-drug-stub}}